Royal Bank of Canada Raises IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $61.00
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective raised by Royal Bank of Canada from $53.00 to $61.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have an outperform rating on the stock. Other equities analysts have also issued reports about the stock. Mizuho assumed coverage on shares […]
More Stories
Global Payments (NYSE:GPN) Upgraded to “Buy” at StockNews.com
StockNews.com upgraded shares of Global Payments (NYSE:GPN – Free Report) from a hold rating to a buy rating in a...
MacroGenics (NASDAQ:MGNX) Earns Neutral Rating from HC Wainwright
HC Wainwright reissued their neutral rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report sent to...
JinkoSolar (NYSE:JKS) Lifted to “Hold” at StockNews.com
StockNews.com upgraded shares of JinkoSolar (NYSE:JKS – Free Report) from a sell rating to a hold rating in a research...
StockNews.com Lowers Flowers Foods (NYSE:FLO) to Buy
StockNews.com downgraded shares of Flowers Foods (NYSE:FLO – Free Report) from a strong-buy rating to a buy rating in a...
Embraer (NYSE:ERJ) Stock Rating Reaffirmed by Bank of America
Bank of America reiterated their buy rating on shares of Embraer (NYSE:ERJ – Free Report) in a report published on...
Remo Canessa Sells 8,455 Shares of Zscaler, Inc. (NASDAQ:ZS) Stock
Zscaler, Inc. (NASDAQ:ZS – Get Free Report) CFO Remo Canessa sold 8,455 shares of the firm’s stock in a transaction...